We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 0.03%
This Fund
S&P 500
This Quarter Est. Return
+6.08%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
–
AUM
$1.82B
AUM Growth
-$235M
Cap. Flow
-$332M
Cap. Flow %
-18.22%
Top 10 Hldgs %
24.45%
Holding
188
New
30
Increased
38
Reduced
74
Closed
46

Top Buys

Rank Stock Value
1
PGNY icon
Progyny
PGNY
+$42.3M
2
LYFT icon
Lyft
LYFT
+$31.7M
3
CNXC icon
Concentrix
CNXC
+$24.7M
4
XRAY icon
Dentsply Sirona
XRAY
+$22.4M
5
GPN icon
Global Payments
GPN
+$21.4M

Top Sells

Rank Stock Value
1
ILMN icon
Illumina
ILMN
+$31.5M
2
APTV icon
Aptiv
APTV
+$26.6M
3
ES icon
Eversource Energy
ES
+$22.4M
4
FTDR icon
Frontdoor
FTDR
+$22.4M
5
ETSY icon
Etsy
ETSY
+$22.2M

Sector Composition

Rank Sector Weight
1 Technology 23.33%
2 Consumer Discretionary 13.44%
3 Healthcare 11.83%
4 Communication Services 9.64%
5 Consumer Staples 9.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GPN icon
1
Global Payments
GPN
$23.9B
$69.9M 3.84%
682,257
+205,851
+43% +$21.4M
MTB icon
2
M&T Bank
MTB
$36.6B
$50.2M 2.76%
281,766
+98,930
+54% +$16.4M
LYFT icon
3
Lyft
LYFT
$5.87B
$45.3M 2.49%
3,549,960
+2,653,774
+296% +$31.7M
VTRS icon
4
Viatris
VTRS
$20.8B
$43.6M 2.4%
3,759,543
-531,051
-12% -$6.13M
ZM icon
5
Zoom
ZM
$26.8B
$42.7M 2.34%
611,719
-121,546
-17% -$7.6M
ES icon
6
Eversource Energy
ES
$28.4B
$42.6M 2.34%
626,648
-347,339
-36% -$22.4M
CLVT icon
7
Clarivate
CLVT
$1.53B
$42M 2.31%
5,918,561
-835,912
-12% -$5.33M
SOLV icon
8
Solventum
SOLV
$14.9B
$40.8M 2.24%
584,883
-239,302
-29% -$14.4M
CHRD icon
9
Chord Energy
CHRD
$7.25B
$34.3M 1.88%
263,340
-22,402
-8% -$3.44M
T icon
10
AT&T
T
$169B
$33.6M 1.85%
1,529,120
-875,572
-36% -$17.4M
SSNC icon
11
SS&C Technologies
SSNC
$18.8B
$31.9M 1.75%
429,493
-229,613
-35% -$16.3M
ST icon
12
Sensata Technologies
ST
$6.8B
$30.8M 1.69%
857,669
+93,254
+12% +$3.47M
TAP icon
13
Molson Coors Class B
TAP
$7.97B
$29.9M 1.64%
519,377
+294,596
+131% +$15.8M
PGNY icon
14
Progyny
PGNY
$2.41B
$29.5M 1.62%
+1,760,706
New +$42.3M
OVV icon
15
Ovintiv
OVV
$16.4B
$29.4M 1.61%
767,085
-23,332
-3% -$1.01M
NOMD icon
16
Nomad Foods
NOMD
$1.7B
$29.2M 1.61%
1,532,709
+92,844
+6% +$1.71M
EXPE icon
17
Expedia Group
EXPE
$35.5B
$27.9M 1.53%
188,251
-65,260
-26% -$8.65M
VZ icon
18
Verizon
VZ
$201B
$27.2M 1.5%
606,313
-308,448
-34% -$12.9M
DNB
19
DELISTED
Dun & Bradstreet
DNB
$25.2M 1.39%
2,190,800
+142,614
+7% +$1.58M
NEM icon
20
Newmont
NEM
$96.4B
$25.2M 1.39%
471,699
-96,049
-17% -$4.77M
STT icon
21
State Street
STT
$50.2B
$24.5M 1.34%
276,591
+43,221
+19% +$3.56M
UPWK icon
22
Upwork
UPWK
$1.21B
$24.4M 1.34%
2,334,612
+260,274
+13% +$2.71M
CNXC icon
23
Concentrix
CNXC
$1.55B
$24.2M 1.33%
472,243
+368,295
+354% +$24.7M
PYPL icon
24
PayPal
PYPL
$51.4B
$24.1M 1.33%
309,049
-153,923
-33% -$10.3M
XRAY icon
25
Dentsply Sirona
XRAY
$2.7B
$23.7M 1.3%
+876,733
New +$22.4M
1
2 3 4 5

Similar funds

SIG
Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return
CAG
Csenge Advisory Group Clearwater, Florida $2.18B AUM 16.73% 1-Year Est. Return
SCP
Seizert Capital Partners Birmingham, Michigan $2.17B AUM 11.2% 1-Year Est. Return
OWP
Obermeyer Wealth Partners Aspen, Colorado $2.17B AUM 19.33% 1-Year Est. Return
ORCP
One Rock Capital Partners New York $2.19B AUM
ET
Entropy Technologies New York $2.17B AUM 21.46% 1-Year Est. Return
MMLI
Massachusetts Mutual Life Insurance Springfield, Massachusetts $2.17B AUM 48.68% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

Invenomic Capital Management's Q3 2024 Portfolio in Review

As of Q3 2024, Invenomic Capital Management held 188 positions worth $1.82B, down 11% from $2.05B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Invenomic Capital Management withdrew a net $332M in Q3 2024, closing 46 positions and reducing 74 holdings. Its most notable exit was Aptiv, an estimated $26.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Invenomic Capital Management opened a new position in Progyny worth $29.5M.

  • Invenomic Capital Management's largest Q3 2024 buy was Progyny: 1,760,706 shares worth $29.5M.
  • Invenomic Capital Management added most to Lyft in Q3 2024, an estimated $31.7M increase.
  • Invenomic Capital Management's biggest Q3 2024 reduction was Illumina, cutting an estimated $31.5M.
  • Invenomic Capital Management fully exited Aptiv in Q3 2024, selling an estimated $26.6M.
  • Invenomic Capital Management's ten largest holdings make up 24% of its $1.82B portfolio in Q3 2024.
  • Invenomic Capital Management opened 30 new positions and closed 46 in Q3 2024.
  • Invenomic Capital Management's portfolio value fell 11% quarter-over-quarter to $1.82B.

Based on Invenomic Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.